NODES_Inndiana_D14_RM4_Biphenyl Amides as Dual-Targeting SOCE/DHODH Inhibitors
The patent application titled “Biphenyl Amides as Dual-Targeting SOCE/DHODH Inhibitors” (No. 102024000024384) describes novel biphenyl amides that can simultaneously modulate Store-Operated Calcium Entry (SOCE) and human dihydroorotate dehydrogenase (hDHODH) for the treatment of autoimmune, inflammatory, and chronic degenerative diseases, as well as neurodegenerative and multisystem inflammatory diseases associated with SOCE overactivation and DHODH pathway alterations.
Institutions
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-12-02
- DOI
- https://doi.org/10.5281/zenodo.14260531
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00